Keros Therapeutics announced that it appointed Alpna Seth, Ph.D., to its Board of Directors, effective May 1, 2023. Dr. Seth served as the President and Chief Executive Officer of Nura Bio Inc. for three years, until she retired in October 2022.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on KROS:
- Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors
- Keros Therapeutics management to meet virtually with Piper Sandler
- Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
- Keros Therapeutics reports Q4 EPS ($1.09), consensus ($1.10)
- Keros Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
